Increased B Cell and Cytotoxic NK Cell Proportions and Increased T Cell Responsiveness in Blood of Natalizumab-Treated Multiple Sclerosis Patients
Figure 1
Overview of lymphocyte populations in patients before and after one year of natalizumab treatment.
a: Distribution of lymphocytes (% of total leukocytes). Comparisons are pairwise. Bars denote mean values. b-c: Relative distribution of discrete lymphocyte subpopulations before (b) and after (c) natalizumab treatment.